These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8593385)

  • 41. [Chemotherapy with isoniazid and rifampicin for pulmonary tuberculosis].
    Kawakami K
    Kekkaku; 2002 Aug; 77(8):569-71. PubMed ID: 12235849
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pulmonary infection with Mycobacterium kansasii in Wales, 1970-9: review of treatment and response.
    Banks J; Hunter AM; Campbell IA; Jenkins PA; Smith AP
    Thorax; 1983 Apr; 38(4):271-4. PubMed ID: 6867979
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Short-term initial chemotherapy with isoniazid, rifampin and ethambutol (streptomycin) in biphasic (3+6) administration, from the intermittent (2/7) beginning. Results after 2 years (cooperative experiment)].
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1977; 26(2):79-90. PubMed ID: 195328
    [No Abstract]   [Full Text] [Related]  

  • 44. Two excellent management tools for national tuberculosis programmes: history of prior treatment and sputum status at two months.
    Trébucq A; Rieder HL
    Int J Tuberc Lung Dis; 1998 Mar; 2(3):184-6. PubMed ID: 9526189
    [No Abstract]   [Full Text] [Related]  

  • 45. [Acquired rifampicin resistance during M. kansasii infection in a patient with AIDS].
    Dautzenberg B; Antoun F; Truffot C
    Rev Mal Respir; 1992; 9(4):464-6. PubMed ID: 1509191
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Crescentic glomerulonephritis due to rifampin treatment in a patient with pulmonary atypical mycobacteriosis.
    Ogata H; Kubo M; Tamaki K; Hirakata H; Okuda S; Fujishima M
    Nephron; 1998; 78(3):319-22. PubMed ID: 9546693
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Short term chemotherapy of tuberculosis. Evaluation of an 18-week-long treatment including pyrazinamide (preliminary results)].
    Pretet S; Grosset J; Perdrizet S
    Bull Int Union Tuberc; 1978 Dec; 53(4):260-1. PubMed ID: 387140
    [No Abstract]   [Full Text] [Related]  

  • 48. Rifabutin in the treatment of cavitary lung disease due to Mycobacterium gordonae.
    Nathan V; Mehta JB; Dralle W
    South Med J; 1993 Jul; 86(7):839-41. PubMed ID: 8391724
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ultrashort-course chemotherapy for culture-negative pulmonary tuberculosis--a qualified success.
    Cowie RL; Langton ME; Escreet BC
    S Afr Med J; 1985 Dec; 68(12):879-80. PubMed ID: 4071345
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pulmonary disease caused by nontuberculosis mycobacteria.
    Tellis CJ; Putnam JS
    Med Clin North Am; 1980 May; 64(3):433-46. PubMed ID: 6993809
    [No Abstract]   [Full Text] [Related]  

  • 51. Short-course intensive treatment of patients with destructive pulmonary tuberculosis.
    Bondarev IM
    Scand J Respir Dis Suppl; 1978; 102():53-5. PubMed ID: 278216
    [No Abstract]   [Full Text] [Related]  

  • 52. [Methodology and results of combination therapy of relapses of pulmonary tuberculosis].
    Smagulov AS; Sakhipova NK; V'iukova RN; Stambekov AS
    Probl Tuberk; 1979 May; (5):21-5. PubMed ID: 471990
    [No Abstract]   [Full Text] [Related]  

  • 53. Sulfonamide-containing regimens for disease caused by rifampin-resistant Mycobacterium kansasii.
    Ahn CH; Wallace RJ; Steele LC; Murphy DT
    Am Rev Respir Dis; 1987 Jan; 135(1):10-6. PubMed ID: 3800137
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Nontuberculous mycobacterial infections of the lung].
    Latshang TD; Lo Cascio CM; Russi EW
    Ther Umsch; 2011 Jul; 68(7):402-6. PubMed ID: 21728159
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Infection by Mycobacterium szulgai in a patient with pulmonary tuberculosis.
    Olmos JM; Peralta FG; Mellado A; González-Macías J
    Eur J Clin Microbiol Infect Dis; 1994 Aug; 13(8):689-90. PubMed ID: 7813507
    [No Abstract]   [Full Text] [Related]  

  • 56. [The combination therapy of clarithromycin and sparfloxacin for pulmonary Mycobacterium gordonae infection].
    Tomiyama Y; Maesaki S; Yong B; Higashiyama Y; Miyazaki Y; Tomono K; Tashiro T; Kohno S
    Kekkaku; 1999 May; 74(5):457-61. PubMed ID: 10386036
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modern treatment of tuberculosis.
    Dutt AK; Stead WW
    Compr Ther; 1982 Sep; 8(9):19-28. PubMed ID: 7140206
    [No Abstract]   [Full Text] [Related]  

  • 58. Evaluation of isoniazid administration on pulmonary tuberculous patients with isoniazid-resistant strain.
    Oka S; Motomiya M; Sato H; Fujimoto M
    Sci Rep Res Inst Tohoku Univ Med; 1967 Nov; 14(3):177-80. PubMed ID: 4978373
    [No Abstract]   [Full Text] [Related]  

  • 59. [Current short-term chemotherapy of tuberculosis. Fundamentals, assumptions, drug combinations, plan of treatment and prospects].
    Radenbach KL
    Internist (Berl); 1978 Dec; 19(12):672-9. PubMed ID: 370048
    [No Abstract]   [Full Text] [Related]  

  • 60. Pulmonary infection with mycobacterium xenopi: review of treatment and response.
    Banks J; Hunter AM; Campbell IA; Jenkins PA; Smith AP
    Thorax; 1984 May; 39(5):376-82. PubMed ID: 6740540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.